Tapered implantable device and methods for making such devices

Abstract
A tapered implantable device includes an ePTFE tubular member having a tapered length portion. The tapered length portion provides rapid recovery properties. The tapered length portion can feature a microstructure that includes a multiplicity of bent fibrils.
Description
TECHNICAL FIELD

This document relates to tapered implantable devices and methods for making such devices that may be used for providing a lumen for fluid flow in bodily cavities, organs, and vessels within a patient.


BACKGROUND

Medical devices are frequently used to treat the anatomy of patients. Such devices can be permanently or semi-permanently implanted in the anatomy to provide treatment to the patient. Frequently, these devices, including stents, grafts, stent-grafts, filters, valves, occluders, markers, mapping devices, therapeutic agent delivery devices, prostheses, pumps, bandages, and other endoluminal and implantable devices, are inserted into the body at an insertion point and delivered to a treatment site.


Devices such as grafts and stent-grafts are used in a variety of places in the human body to repair, support, and/or replace anatomical lumens, such as blood vessels, respiratory ducts, gastrointestinal ducts, and the like. Such devices can, for example, provide lumens for fluid flow. In such configurations, flexible and durable devices are needed.


In various applications, such as particular vascular applications, it is desirable to utilize a graft or artificial lumen having a tapered length portion. Tapered length portion and/or grafts may also be useful in connecting discreet grafts or tubes of differing diameters. As such, there is an ongoing need to provide tapered implantable devices, such as grafts and/or stent-grafts, which have improved flexibility and/or rapid recovery properties. Such devices may improve characteristics of the blood flow of a patient and reduce thrombosis.


SUMMARY

In a first general aspect, a tapered implantable device for repairing or replacing a lumen in the body of a patient comprises a tubular member, such as an ePTFE tubular member, having a tapered portion. The tapered portion includes a multiplicity of substantially bent fibrils, providing a region having rapid recovery properties.


In various implementations, a tapered implantable device in accordance with the present disclosure is formed by stretching a smaller diameter polymeric tubular member over a first mandrel having larger and smaller opposing ends and an intermediate tapered length segment to create a first tapered length portion on the polymeric tubular mandrel. The tubular member is then longitudinally compressed on a second mandrel to form the tapered implantable device by converting the first tapered length portion into a second tapered length portion having a multiplicity of bent fibrils. The tapered implantable device is then removed from the second mandrel and prepared for implantation into the anatomy of a patient.


The details of one or more embodiments are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and the drawings, and from the claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of a portion of a tapered implantable device in accordance with the present disclosure;



FIG. 2 is a schematic representation of a microstructure of ePTFE material in accordance with the present disclosure;



FIG. 3A is a side view of a first tapered mandrel, and FIG. 3B is a side view of a tapered implantable device in a stage of formation; and



FIG. 4A is a side view of a second tapered mandrel, FIG. 4B is a side view of a tapered implantable device in another stage of formation, and FIG. 4C is a side view of a second tapered mandrel and complimentary female die.





Like reference symbols in the various drawings indicate like elements. It should also be noted that the accompanying drawing figures referred to herein are not all drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in that regard, the drawing figures should not be construed as limiting.


DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS

This document describes devices, systems, and methods that are useful, for example, for repairing, supporting, and/or replacing anatomical lumens. Several implantable medical devices are described herein, and in general any of the features described with respect to a particular device may also be used with any of the other devices described herein. In some examples, one or more features described with respect to a particular device may be added to or included with another device. Also, various combinations or sub-combinations of any of the features described herein may generally be used with any of the devices described herein.


In general, any of the implantable devices described herein can be delivered to, and deployed at, an in vivo deployment site within a body of a patient using various minimally invasive surgical techniques. Likewise, these devices may also be surgically implanted via vascular surgical techniques.


Further, any of the implantable medical devices described herein can be delivered to, and deployed at, an in vivo deployment site within a body of a patient using various minimally invasive transcatheter deployment techniques.


Any of the implantable medical devices discussed herein can be used to repair, replace, and/or provide support to a body lumen. In various embodiments, implantable medical devices of the present disclosure can be used in a body lumen, including those within the circulatory and gastrointestinal systems.


As used herein, “implantable” means implanted in the body of a patient for more than 29 days.


As used herein, “taper” or “tapered” generally refers to a region of transition from one portion of a device to another portion of the same device. Most typically, a taper transitions a portion of a tubular device having a circular transverse cross-section with a larger inside diameter to another portion of the same device having a circular transverse cross-section with a smaller inner diameter. The region can be symmetrically or asymmetrically conical, or may be shaped to include bumps, reversals, or flares.


For the sake of consistency and clarity, the term “portion” is used to identify a length of, for example, a tubular member. The term “segment” is used to identify a length of, for example, a first or second mandrel. These terms are not intended to be limiting, and are chosen primarily to assist in understanding the references to various tubular members and mandrels.



FIG. 1 illustrates an example tapered implantable device 100 comprising a polymeric tubular member 102 having a first smaller diameter length portion 104, a second larger diameter length portion 106, and a tapered length portion 108. Polymeric tubular member 102 can, for example, comprise an axially compressible polymeric material, such as a longitudinally extruded and expanded polymer, including expanded polytetrafluoroethylene (“ePTFE”), expanded modified PTFE, expanded copolymers of PTFE, nylons, polycarbonates, polyethylenes, polypropylenes, polyurethanes and the like. In various embodiments, polymeric tubular member 102 comprises an extruded ePTFE tube, such as the tubes described in U.S. Pat. Nos. 3,953,566 and 4,187,390. In other embodiments, polymeric tubular member 102 comprises a wrapped ePTFE film tube. For example, member 102 can comprise a tube made from an ePTFE film that has been cigarette wrapped on the surface of a mandrel or, alternatively, has been helically wrapped on the surface of a mandrel. Such ePTFE films of this type can be made generally as taught by U.S. Pat. Nos. 3,953,566 and 4,187,390. In yet other embodiments, member 102 can comprise a polymeric open celled material. However, any suitable polymeric tubular member is within the scope of the present disclosure.


In various embodiments, polymeric tubular member 102 comprises an ePTFE tube having microstructure of nodes interconnected by fibrils. The microstructure of polymeric tubular member 102 can comprise a multiplicity of fibrils having a mean fibril length. Mean fibril length can be determined, for example, by examining a photomicrograph of the surface of polymeric tubular member 102 and by taking the mean of ten measurements made in the predominant direction of the fibrils between nodes connected by fibrils. First, a photomicrograph is made of a representative region of the sample surface, of adequate magnification to show at least five sequential fibrils within the length of the photomicrograph. A series of five measurements are taken along a straight line drawn onto the surface of the photomicrograph in the predominant direction of the fibrils followed by a second series of five measurements made along a second line drawn parallel to the first. A measurement constitutes the distance between adjacent nodes connected by at least one fibril. The ten measurements obtained by this method are averaged to obtain the mean fibril length of the region.


For example, as illustrated in FIG. 2, any or all of length portions 102, 108, and 106 can have a multiplicity of bent fibrils 214.


Tapered length portion 108 can, for example, possess a rapid recovery property, i.e., a spring-like property. Rapid recovery as herein defined is the difference between the extended length of a material and the recovered length with respect to the recovered length, as generally described in U.S. Pat. No. 5,026,513. The extended length is the length of material under tensile load and recovered length is the length of material. In various embodiments, rapid recovery can be quantified by the following equation:







RR





%

=


(


l
t

-

l
r


)

×
100

%







(

l
r

)





where lt is the length of the tapered length portion 108 when extended axially under 1% maximum tensile force, and lr is the length of the tapered portion five seconds after the release of the tensile force. Tapered length portion 108 having rapid recovery properties can, for example, exhibit improved bending characteristics and improved resistance to kinking, constriction, and/or collapse under bending.


In various embodiments, tapered length portion 108 can comprise a uniform frustoconical section. In such embodiments, tapered length portion 108 expands in the manner of a uniform frustoconical section from a diameter of first smaller diameter length portion 104 to a diameter of second larger diameter length portion 106.


In other embodiments, tapered length portion 108 comprises a non-uniform shape. For example, tapered length portion 108 can expand from a diameter of first smaller diameter length portion 104 to a diameter of second larger diameter length portion 106 in a non-uniform manner, such as a curved, non-linear shape. Any shape of tapered length portion 108 is within the scope of the present disclosure.


A method for making a tapered implantable device of the present disclosure is described as follows. A polymeric tubular member is fitted over a first mandrel having first, longer tapered length segment to form a first tapered length portion along a portion of the length of the polymeric tubular member. The polymeric tubular member is removed from the first mandrel and fitted over and axially compressed onto a second mandrel having a second, shorter tapered length segment to form the first tapered length portion into a second tapered length portion. A female die can optionally be used assist in compression of the polymeric tubular member on the second mandrel, particularly over the second tapered length portion. The polymeric tubular member can then be removed from the second mandrel.



FIGS. 3A and 3B illustrate an example step in a method to form a tapered implantable implant. Polymeric tubular member 102 is fitted over a first mandrel 330. First mandrel 330, as shown in FIG. 3A, comprises a smaller diameter length segment 334, a larger diameter length segment 336, and a first, longer tapered length segment 338. First, longer tapered length segment 338 is typically located between smaller diameter length segment 334 and larger diameter length segment 336.


In various embodiments, polymeric tubular element 102 initially comprises a diameter (consistent along its length) equal to or slightly less than the diameter of smaller diameter length segment 334. Polymeric tubular member 102 is placed around the exterior surface of first mandrel 330 and pulled onto the mandrel in the direction of the first larger diameter length segment 336. In various embodiments, as polymeric tubular member 102 is fitted over first mandrel 330 it is stretched over first, longer tapered length segment 338 to larger diameter length segment 336, forming second larger diameter length portion 106 and tapered portion having a first longer length 318.


In various embodiments, the respective lengths of larger diameter length portion 104 and smaller diameter length portion 106 can be selected to position tapered portion having a first longer length 318 at a desired position onto polymeric tubular member 102. For example, a tapered implantable device having a particular length of a larger diameter and particular length of a shorter diameter may be desired. It can also be appreciated that the tapered implantable device may be continuously tapered between the opposing ends of the device. By providing a method for placing a tapered portion having a multiplicity of bent fibrils between a smaller diameter length portion 104 and a larger diameter length portion 106, a tapered implantable device 100 having at least sufficient length of smaller diameter length portion 104 and larger diameter length portion 106 can be formed. In such embodiments, tapered implantable device 100 can be sized by, for example, cutting one or both ends of polymeric tubular member 102 such that a sufficient length of smaller diameter length portion 104 and larger diameter length portion 106 is provided.


Prior to removal of polymeric tubular member 102 from first mandrel 330, member 102 can be exposed to further processing steps. For example, polymeric tubular member 102 can be wrapped with a biocompatible reinforcing film, such as an ePTFE film. Any biocompatible material capable of reinforcing polymeric tubular member 102 is within the scope of the present disclosure.


For example, a length portion of polymeric tubular member 102, such as tapered length portion with a first longer length 318, can be heated. Further, heat can be applied to the entire first mandrel 330 and polymeric tubular member 102. Any processing of polymeric tubular member 102, including tapered length portion having a first longer length 318, is within the scope of the present disclosure.


In various embodiments, the outer surface of porous tubular member 102 can be coated with an elastomer. For example, as referenced in U.S. Pat. No. 8,029,563, a silicone composition such as MED-1137 Adhesive Silicone Type A from NuSil Silicone Technology (Carpenteria, Calif.) can be applied to the outer surface of porous tubular member 102. In various embodiments, the elastomer is applied after porous tubular member 102 is heated. Any application of elastomer to porous tubular member 102 is within the scope of the present disclosure.


Further, prior to removal from first mandrel 330, porous tubular member 102 can be surrounded by an optional second porous tubular member. In various embodiments, the optional second porous tubular member comprises a larger inner diameter than an outer diameter of the porous tubular member 102. The optional second porous tubular member can be positioned concentrically around first tubular member 102 on mandrel 330.


As illustrated in FIG. 4A, a second mandrel 440 can comprise a larger diameter length segment 446, a smaller diameter length segment 444, and a second, shorter tapered length segment 448. Second, shorter tapered length segment 448 is typically located between smaller diameter length segment 444 and larger diameter length segment 446.


With reference to FIG. 4B, polymeric tubular member 102 having a tapered portion with a first longer length 318 can be fitted over second tubular mandrel 440 such that tapered length portion 318 is located at or near second, shorter tapered length segment 448. Polymeric tubular member 102 can then be compressed longitudinally along second mandrel 440 in the direction of a larger diameter length segment 446, which converts tapered portion having a first longer length 318 to a tapered portion having a second shorter length 108. In such embodiments, shorter diameter length portion 104 and longer diameter length portion 106 of polymeric tubular member 102 do not experience a significant length change, as only tapered portion having a first longer length 318 is compressed against an exterior surface of second mandrel 440. As such, as previously described, the desired dimensions of tapered implantable device 100 can be selected prior to formation of tapered portion having a second shorter length 108.


A compression ratio can be used to describe the amount of longitudinal compression applied to tapered portion having a first longer length 318. For example, a compression ratio can comprise a ratio of the length tapered portion having a second shorter length 108 to the length of tapered portion having a first longer length 318. In various embodiments, the compression ratio can be between about 75% and 95%. In other embodiments, the compression ratio can be between about 50% and 75%. In yet other embodiments, the compression ratio can be between about 25% and 50%. The compression ratio may range as low as about 15%, and is largely dependent on the bulk density of the chosen porous precursor material.


In various embodiments, the compression ratio can correlate with the respective lengths of tapered portion having a second shorter length 108 and tapered portion having a first longer length 318. For example, a mandrel ratio can comprise the ratio of the length of second, shorter tapered length segment 448 to the length of first, longer tapered length segment 338. Preferably, the compression ratio and the mandrel ratio are substantially the same. In other embodiments, the mandrel ratio is within 10% of the compression ratio. In yet other embodiments, the mandrel ratio is within 33% of the compression ratio. Any correlation between the compression ratio and the mandrel ratio is within the scope of the present disclosure.


In various embodiments, as illustrated in FIG. 4C, a female die 450 can be used to assist in formation of tapered portion having a second shorter length 108. For example, female die 450 can apply a longitudinally compressive force against polymeric tubular member 102 at or near second, shorter tapered length segment 448, causing tapered portion having a first longer length 318 to compress against second, shorter tapered length segment 448 of second mandrel 440. Female die 450 can comprise, for example, a complementary shape to second, shorter tapered length segment 448 of second mandrel 440. In other embodiments, female die 450 comprises a shape different from that of second, shorter tapered length segment 448. In such embodiments, female die 450 can assist in providing a desired shape on an external surface of polymeric tubular member 102, including tapered portion having a second shorter length 108.


Further, female die 450 can assist in providing a consistent thickness of polymeric tubular member 102 in the smaller diameter region 104 and/or the tapered portion having a second shorter length 108. Any configuration of female die 450 that assists in forming tapered portion having a second shorter length 108 in a porous tubular member is within the scope of the present disclosure.


Prior to removal of polymeric tubular member 102 from second mandrel 440, member 102 can be exposed to further processing steps. For example, a portion of polymeric tubular member 102, such as tapered portion with a second shorter length 108, can be heated. Further, heat can be applied to the entire second mandrel 440 and polymeric tubular member 102. Any processing of polymeric tubular member 102, including tapered portion having a second shorter length 108, is within the scope of the present disclosure.


After formation of tapered portion having a second shorter length 108, tapered implantable device 100 can be removed from second mandrel 440 and prepared for use in the anatomy of a patient. In various embodiments, tapered implantable device 100 can be combined with a medical device such as, for example, a stent. In other embodiments, tapered implantable device 100 can be used without combination with another medical device. In such embodiments, tapered implantable device 100 can comprise a graft. Although described in particular embodiments, tapered implantable device 100 can be used alone or in combination with any suitable medical device for implantation within the anatomy of a patient.


Several characteristics and advantages have been set forth in the preceding description, including various alternatives together with details of the structure and function of the devices and methods. The disclosure is intended as illustrative only and as such is not intended to be exhaustive or limiting. It will be evident to those skilled in the art that various modifications may be made, especially in matters of structure, materials, elements, components, shapes, sizes, and arrangements of parts including combinations within the principles described herein, to the full extent indicated by the broad, general meaning of the terms in which the appended claims are expressed. To the extent that these various modifications depart from the spirit and scope of the appended claims, they are intended to be encompassed therein.

Claims
  • 1. An implantable article comprising: an expanded polytetrafluoroethylene (ePTFE) tube comprising a first length portion having a first diameter and a second length portion having a second diameter; anda tapered length portion between the first length portion and the second length portion and having a shorter length than at least one of the first length portion and the second length portion, wherein the tapered length portion comprises a multiplicity of compressed bent fibrils such that the tapered length portion is characterized by a tapered length portion rapid recovery property with a compression ratio between 30% and 95%, a difference between an extended length of the tapered length portion and a recovered length of the tapered length portion, that differs from a first rapid recovery property, a difference between an extended length of the first length portion and a recovered length of the first length portion, characterizing the first length portion.
  • 2. The implantable article of claim 1, wherein the tapered length portion comprises a uniform, frustoconical shape.
  • 3. The implantable article of claim 1, wherein the compression ratio of the tapered length portion is between 50% and 95%.
  • 4. An implantable article comprising: an expanded polytetrafluoroethylene (ePTFE) tube comprising a first length portion having a smaller diameter and a second end having a larger diameter; anda tapered length portion between the first length portion and the second end and having a shorter length than at least one of the first length portion and the second length portion, wherein the tapered length portion comprises a multiplicity of compressed bent fibrils such that the tapered length portion is characterized by a rapid recovery property with a compression ratio between 30% and 95%, a difference between an extended length of the tapered length portion and a recovered length of the tapered length portion, that is greater than a rapid recovery property of the first length portion.
  • 5. The implantable article of claim 4, wherein the compression ratio of the tapered length portion is between 50% and 95%.
  • 6. An implantable article comprising: an ePTFE tube comprising a first length portion having a first diameter and a second length portion having a second diameter; anda tapered length portion that includes a uniform frustoconical section between the first length portion and the second length portion and having a shorter length than at least one of the first length portion and the second length portion, wherein the tapered length portion comprises a multiplicity of compressed bent fibrils characterized by a tapered length portion rapid recovery property with a compression ratio between 30% and about 95%, a difference between an extended length of the tapered length portion and a recovered length of the tapered length portion, that differs from a rapid recovery property, a difference between an extended length of the first length portion and a recovered length of the first length portion, characterizing the first length portion.
  • 7. The implantable article of claim 6, wherein the ePTFE tube comprises a multiplicity of bent fibrils.
  • 8. The implantable article of claim 6, wherein the tapered length portion comprises a non-uniform shape.
  • 9. The implantable article of claim 6, wherein the tapered length portion comprises a uniform, frustoconical shape.
  • 10. The implantable article of claim 6, wherein the tapered length portion is characterized by a tapered length portion rapid recovery property that is greater than a rapid recovery property characterizing the first length portion.
  • 11. The implantable article of claim 6, wherein the compression ratio of the tapered length portion is between 50% and 95%.
  • 12. An implantable article comprising: an ePTFE tube comprising a first end having a smaller diameter and a second end having a larger diameter; anda tapered length portion between the first end and the second end and having a shorter length than at least one of the first length portion and the second length portion, wherein the tapered length portion comprises a multiplicity of compressed bent fibrils characterized by a tapered length portion rapid recovery property with a compression ratio between 25% and 95%, a spring like-property that comprises a difference between an extended length of the tapered length portion and a recovered length of the tapered length portion, that differs from a rapid recovery property, a difference between an extended length of the first length portion and a recovered length of the first length portion, characterizing the first length portion.
  • 13. The implantable article of claim 12, wherein the ePTFE tube further comprises a first length portion having the smaller diameter and a second length portion having the larger diameter.
  • 14. The implantable article of claim 12, wherein the ePTFE tube comprises a multiplicity of bent fibrils.
  • 15. The implantable article of claim 12, wherein the tapered length portion comprises a non-uniform shape.
  • 16. The implantable article of claim 12, wherein the tapered length portion comprises a uniform, frustoconical shape.
  • 17. The implantable article of claim 12, wherein the tapered length portion is characterized by a greater rapid recovery property than the first length portion.
  • 18. The implantable article of claim 12, wherein the tapered length portion is characterized by a tapered length portion rapid recovery property that is greater than a rapid recovery property characterizing the first length portion.
  • 19. The implantable article of claim 12, wherein the compression ratio of the tapered length portion is between 50% and 95%.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 14/557,927, filed Dec. 2, 2014, which claims the benefit of U.S. Provisional Application 61/912,339, filed Dec. 5, 2013, both of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (206)
Number Name Date Kind
512151 Briggs Jan 1894 A
3425418 Chvapil et al. Feb 1969 A
3814137 Martinez Jun 1974 A
3914802 Reick Oct 1975 A
3953566 Gore Apr 1976 A
4133927 Tomodoa et al. Jan 1979 A
4177334 Okita Dec 1979 A
4187390 Gore Feb 1980 A
4193138 Okita Mar 1980 A
4208745 Okita Jun 1980 A
4229838 Sumitomo Oct 1980 A
4279245 Takagi et al. Jul 1981 A
4283448 Bowman Aug 1981 A
4304010 Mano Dec 1981 A
4321711 Mano Mar 1982 A
4347204 Takagi et al. Aug 1982 A
4416028 Eriksson et al. Nov 1983 A
4443511 Worden et al. Apr 1984 A
RE31618 Mano Jul 1984 E
4474630 Planck et al. Oct 1984 A
4478898 Kato Oct 1984 A
4550447 Seiler, Jr. et al. Nov 1985 A
4604762 Robinson Aug 1986 A
4613544 Burleigh Sep 1986 A
4619641 Schanzer Oct 1986 A
4657544 Pinchuk Apr 1987 A
4687482 Hanson Aug 1987 A
4692369 Nomi Sep 1987 A
4731073 Robinson Mar 1988 A
4739013 Pinchuk Apr 1988 A
4743252 Martin, Jr. et al. May 1988 A
4743480 Campbell et al. May 1988 A
4759757 Pinchuk Jul 1988 A
4787921 Shibata et al. Nov 1988 A
4804381 Turina et al. Feb 1989 A
4810749 Pinchuk Mar 1989 A
4816339 Tu et al. Mar 1989 A
4850999 Planck Jul 1989 A
4857069 Kira Aug 1989 A
4871361 Kira Oct 1989 A
4875468 Krauter et al. Oct 1989 A
4877661 House et al. Oct 1989 A
4882113 Tu Nov 1989 A
4891407 Mitchell Jan 1990 A
4921495 Kira May 1990 A
4932964 Bittmann et al. Jun 1990 A
4945125 Dillon et al. Jul 1990 A
4955899 Coma et al. Sep 1990 A
4957669 Primm Sep 1990 A
4969896 Shors Nov 1990 A
4973609 Browne Nov 1990 A
5024671 Tu Jun 1991 A
5026513 House Jun 1991 A
5061276 Tu Oct 1991 A
5064593 Tamaru et al. Nov 1991 A
5066683 Dillon et al. Nov 1991 A
5071609 Tu et al. Dec 1991 A
5084065 Weldon et al. Jan 1992 A
5100422 Berguer et al. Mar 1992 A
5104400 Berguer et al. Apr 1992 A
5116360 Pinchuk et al. May 1992 A
5123917 Lee Jun 1992 A
5128092 Asaumi et al. Jul 1992 A
5133742 Pinchuk Jul 1992 A
5152782 Kowligi et al. Oct 1992 A
5192310 Herweck et al. Mar 1993 A
5217797 Knox et al. Jun 1993 A
5229431 Pinchuk Jul 1993 A
5290271 Jernberg Mar 1994 A
5320888 Stevens Jun 1994 A
5354329 Whalen Oct 1994 A
5358516 Myers et al. Oct 1994 A
5370681 Herweck et al. Dec 1994 A
5453235 Calcote et al. Sep 1995 A
5466252 Soukup et al. Nov 1995 A
5476589 Bacino Dec 1995 A
5584876 Bruchman et al. May 1996 A
5527353 Schmitt Jun 1996 A
5529820 Nomi et al. Jun 1996 A
5549664 Hirata et al. Aug 1996 A
5556426 Popadiuk et al. Sep 1996 A
5607478 Lentz et al. Mar 1997 A
5609624 Kalis Mar 1997 A
5620763 House et al. Apr 1997 A
5628782 Myers et al. May 1997 A
5628788 Pinchuk May 1997 A
5641373 Shannon et al. Jun 1997 A
5647400 Jani et al. Jul 1997 A
5665114 Weadock et al. Sep 1997 A
5700287 Myers et al. Dec 1997 A
5708044 Branca Jan 1998 A
5716395 Myers et al. Feb 1998 A
5716660 Weadock et al. Feb 1998 A
5718973 Lewis et al. Feb 1998 A
5735892 Myers et al. Apr 1998 A
5749880 Banas et al. May 1998 A
5788626 Thompson Aug 1998 A
5789047 Sasaki et al. Aug 1998 A
5800510 Schmitt Sep 1998 A
5800512 Lentz et al. Sep 1998 A
5800514 Nunez Sep 1998 A
5824050 Karwoski et al. Oct 1998 A
5840240 Stenoien Nov 1998 A
5843173 Shannon et al. Dec 1998 A
5851229 Lentz et al. Dec 1998 A
5851230 Lentz et al. Dec 1998 A
5866217 Stenoien et al. Feb 1999 A
5897587 Martakos et al. Apr 1999 A
5904967 Ezaki et al. May 1999 A
5910168 Myers et al. Jun 1999 A
5931865 Silverman et al. Aug 1999 A
5976192 McIntyre et al. Nov 1999 A
6001125 Golds et al. Dec 1999 A
6016848 Egres et al. Jan 2000 A
6027779 Campbell et al. Feb 2000 A
6036724 Lentz et al. Mar 2000 A
6039755 Edwin Mar 2000 A
6042666 Karwoski et al. Mar 2000 A
6053939 Okuda et al. Apr 2000 A
6056970 Greenawalt et al. May 2000 A
6080198 Lentz et al. Jun 2000 A
6099557 Schmitt Aug 2000 A
6159565 Campbell et al. Dec 2000 A
6165211 Thompson Dec 2000 A
6187054 Colone et al. Feb 2001 B1
6203735 Edwin Mar 2001 B1
6267834 Shannon et al. Jul 2001 B1
6287337 Martakos et al. Sep 2001 B1
6319279 Shannon et al. Nov 2001 B1
6328762 Anderson et al. Dec 2001 B1
6338904 Patnaik et al. Jan 2002 B1
6346273 Saettone Feb 2002 B1
6368347 Maini et al. Apr 2002 B1
6416537 Martakos et al. Jul 2002 B1
6428571 Lentz et al. Aug 2002 B1
6436135 Goldfarb Aug 2002 B1
6517571 Brauker et al. Feb 2003 B1
6517858 LeMoel et al. Feb 2003 B1
6521284 Parsons et al. Feb 2003 B1
6534084 Vyakarnam et al. Mar 2003 B1
6541589 Baillie Apr 2003 B1
6547820 Staudenmeier Apr 2003 B1
6589468 Schmitt Jul 2003 B1
6663614 Carter Dec 2003 B1
6712919 Ruefter et al. Mar 2004 B2
6716239 Sowinski Apr 2004 B2
6719783 Lentz et al. Apr 2004 B2
6790226 Edwin et al. Sep 2004 B2
6814753 Schmitt Nov 2004 B2
6827737 Hill et al. Dec 2004 B2
6863686 Shannon et al. Mar 2005 B2
6926735 Henderson Aug 2005 B2
6939377 Jayaraman et al. Sep 2005 B2
7056336 Armstrong et al. Jun 2006 B2
7056387 Van Der Steur Jun 2006 B2
7108701 Evens et al. Sep 2006 B2
7147617 Henderson et al. Dec 2006 B2
7244271 Lentz et al. Jul 2007 B2
7297158 Jensen Nov 2007 B2
7306729 Bacino et al. Dec 2007 B2
7351257 Kaldany Apr 2008 B2
7396363 Frid Jul 2008 B2
7452374 Hain et al. Nov 2008 B2
7510571 Spiridigliozzi et al. Mar 2009 B2
7531611 Sabol et al. May 2009 B2
7553326 Sweet et al. Jun 2009 B2
7560006 Rakos et al. Jul 2009 B2
8029563 House Oct 2011 B2
8637144 Ford Jan 2014 B2
8906087 House Dec 2014 B2
9139669 Xu et al. Sep 2015 B2
10357385 Schlaud et al. Jul 2019 B2
20020058991 Schmitt May 2002 A1
20020138129 Armstrong Sep 2002 A1
20030004559 Lentz et al. Jan 2003 A1
20030027775 Wallace Feb 2003 A1
20030060871 Hill et al. Mar 2003 A1
20030100859 Henderson et al. May 2003 A1
20030139806 Haverkost et al. Jul 2003 A1
20030153983 Miller et al. Aug 2003 A1
20040024442 Sowinski et al. Feb 2004 A1
20040033364 Spiridigliozzi et al. Feb 2004 A1
20040049264 Sowinksi et al. Mar 2004 A1
20040054406 Dubson et al. Mar 2004 A1
20040122507 Henderson Jun 2004 A1
20040182511 Rakos et al. Sep 2004 A1
20040193242 Lentz et al. Sep 2004 A1
20040215337 Hain et al. Oct 2004 A1
20040265352 Kaldany Dec 2004 A1
20050137677 Rush Jun 2005 A1
20050187607 Akhtar et al. Aug 2005 A1
20050240261 Rakos Oct 2005 A1
20050249776 Chen et al. Nov 2005 A1
20060041318 Shannon Feb 2006 A1
20070116736 Argentieri et al. May 2007 A1
20070276474 Llanos et al. Nov 2007 A1
20070293808 Williams et al. Dec 2007 A1
20080027534 Edwin et al. Jan 2008 A1
20080097592 Fitzpatrick Apr 2008 A1
20080195026 Kim Aug 2008 A1
20080195079 Moore et al. Aug 2008 A1
20090270973 Chen et al. Oct 2009 A1
20110054586 Mayberry Mar 2011 A1
20120130477 Gessaroli May 2012 A1
20150157444 Cully et al. Jun 2015 A1
20190343663 Schlaud et al. Nov 2019 A1
Foreign Referenced Citations (39)
Number Date Country
1466165 Jan 2004 CN
0117072 Aug 1984 EP
0256748 Feb 1988 EP
0266035 May 1988 EP
0391586 Oct 1990 EP
656196 Jul 1995 EP
1131113 Feb 2000 EP
1101458 May 2001 EP
1925270 May 2008 EP
2033232 May 1980 GB
1590101 May 1981 GB
2222954 Mar 1990 GB
6343688 Dec 1994 JP
2739420 Mar 1995 JP
8238263 Sep 1996 JP
11099163 Apr 1999 JP
5176947 Jul 2010 JP
5474514 Jun 2011 JP
5925725 Nov 2014 JP
WO-1995010247 Apr 1995 WO
WO-1996007370 Mar 1996 WO
WO-9826731 Jun 1998 WO
WO-2001021107 Mar 2001 WO
WO-2001032382 May 2001 WO
WO-2001067991 Sep 2001 WO
WO-2002013675 Feb 2002 WO
WO-03015837 Feb 2003 WO
WO-2003084440 Oct 2003 WO
WO-2004060209 Jul 2004 WO
WO-2004096307 Nov 2004 WO
WO-2006007214 Jan 2006 WO
WO-2006026725 Mar 2006 WO
WO-2006038031 Apr 2006 WO
WO-2006058322 Jun 2006 WO
WO-2006085044 Aug 2006 WO
WO-2007061787 May 2007 WO
WO-2007113494 Oct 2007 WO
WO-2007127802 Nov 2007 WO
WO-2007137211 Nov 2007 WO
Non-Patent Literature Citations (12)
Entry
European Search Report from EP18208417.8, dated Apr. 24, 2019, 8 pages.
Berman M, Pearce W, et al, The use of Gore-Tex E-PTFE bonded to silicone rubber as an alloplastic implant material. Laryngoscope 1986; v96 n5: 480-483.
GORE® Acuseal Cardiovascular Patch Product Information, Jun. 2014, 40 pages.
International Search Report and Written Opinion for PCT/US2014/068411 dated Feb. 12, 2015, corresponding to U.S. Appl. No. 14/557,927, 9 pages.
International Search Report and Written Opinion for PCT/US2016/035857 dated Aug. 4, 2016, corresponding to U.S. Appl. No. 15/173,361, 11 pages.
LeMatire Expedial Vascular Access Graft Product Information/Instructions For Use.
Lumsden AB, Chen C et al. Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models. Journal of Vascular Surgery 1996; v24 n5: 825-833.
Perma-Seal Dialysis Access Graft Instructions for use.
Perma-Seal Dialysis Access Graft Patient Education Brochure.
Sonoda H, Takamizawa K et al. Coaxial double-tubular compliant arterial graft prosthesis: time-dependent morphogenesis and compliance changes after implantation. J Biomed Mater Res 2003: 65A: 170-181.
Sonoda H, Takamizawa K et al. Small-diameter compliant arterial graft prosthesis: Design concept of coaxial double tubular graft and its fabrication. J Biomed Mater Res 2011; 55: 266-276.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2016/035857, dated Dec. 14, 2017, 8 pages.
Related Publications (1)
Number Date Country
20180092733 A1 Apr 2018 US
Provisional Applications (1)
Number Date Country
61912339 Dec 2013 US
Continuations (1)
Number Date Country
Parent 14557927 Dec 2014 US
Child 15786670 US